Personalized medicine: In vitro drug testing on primary cancer cells
18 May 2021Many university hospitals house dedicated research groups to screen small, dedicated drug libraries on primary tumor cells derived from patient biopsies to match potential treatments to different cancer types.
In this eBook, Tecan provides examples of such laboratories working in the area of pediatric oncology with a focus on leukemias or brain tumors. They all share a reliance on miniaturization and fast processing times to screen hundreds of compounds on very limited and precious patient material.
Related Products
Request Quote for All Products
Spark® Cyto
TecanSpark Cyto is the first live cell plate reader to detect biological, chemical or physical events – capturing the maximum amount of data possible from each plate well, at the same time and under the same conditions.
Spark® Multimode Microplate Reader
TecanIncrease your productivity for advanced research and drug discovery with Spark, the first multimode microplate reader with integrated cooling.
D300e Digital Dispenser
TecanThe D300e Digital Dispenser* uses direct digital dispensing technology to enable rapid delivery of picoliter to microliter sample volumes. It delivers fast, reliable performance across a large dynamic range, eliminating the need for slow, error-prone and wasteful serial dilutions for creation of dose-response curves and enabling miniaturized qPCR reaction set-up.